And when the sole therapy available to end-stage prostate cancer patients is Taxotere (docetaxel)—which extends survival by only two-and-a-half months and is so toxic it kills 300 patients ...

There are several types of prostate cancer. The most common type is adenocarcinoma, which grows in the tissue of the prostate gland. But other types of cancer can also originate in the prostate.

Traditionally, men who chose radiation therapy for prostate cancer undergo radiation for weeks or even months. But now, in certain cases, it can be completed in less than a week. Prostate cancer ...

Findings published in the Journal of Clinical Oncology show that one in 20 men with end-stage prostate cancer responded to Keytruda, but although the number who benefited was small, these patients ...

More than one-third of patients with PSA levels less than 0.5 ng/mL after primary radical prostatectomy for prostate cancer have PSMA activity suspicious for recurrence, a new study finds.